COSCIENS Biopharma Inc. Income Tax Expense Continuing Operations
COSCIENS Biopharma Inc. (CSCIF) reported Income Tax Expense Continuing Operations of $10.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Expense Statement
ifrs-full:IncomeTaxExpenseContinuingOperations · last filed 2026-03-25
- COSCIENS Biopharma Inc. income tax expense continuing operations for the quarter ending 2025-06-30 was $1.00K.
- COSCIENS Biopharma Inc. income tax expense continuing operations for the quarter ending 2024-12-31 was $1.08M.
- COSCIENS Biopharma Inc. income tax expense continuing operations for the quarter ending 2024-09-30 was -$112.00K.
- COSCIENS Biopharma Inc. income tax expense continuing operations for the quarter ending 2024-06-30 was -$474.00K.
| Period end | Income Tax Expense Continuing Operations 3 month | Income Tax Expense Continuing Operations 6 month | Income Tax Expense Continuing Operations 9 month | Income Tax Expense Continuing Operations 12 month |
|---|---|---|---|---|
| 2025-12-31 | $10.00K 20-F · filed 2026-03-25 | |||
| 2025-06-30 | $1.00K 6-K · filed 2025-08-14 | $1.00K 6-K · filed 2025-08-14 | ||
| 2024-12-31 | $1.08M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-25 | $970.00K derived: sum of 2 quarters · filed 2026-03-25 | $496.00K derived: sum of 3 quarters · filed 2026-03-25 | $84.00K 20-F · filed 2026-03-25 |
| 2024-09-30 | -$112.00K 6-K · filed 2025-11-12 | -$586.00K derived: sum of 2 quarters · filed 2025-11-12 | -$998.00K 6-K · filed 2025-11-12 | -$1.36M derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-06-30 | -$474.00K 6-K · filed 2025-08-14 | -$886.00K 6-K · filed 2025-08-14 | -$1.25M derived: sum of 3 quarters · filed 2026-03-25 | -$1.46M derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-03-31 | -$412.00K 6-K · filed 2025-05-13 | -$772.00K derived: sum of 2 quarters · filed 2026-03-25 | -$984.00K derived: sum of 3 quarters · filed 2026-03-25 | -$1.22M derived: sum of 4 quarters · filed 2026-03-25 |
| 2023-12-31 | -$360.00K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-25 | -$572.00K derived: sum of 2 quarters · filed 2026-03-25 | -$807.00K derived: sum of 3 quarters · filed 2026-03-25 | -$885.00K 20-F · filed 2026-03-25 |
| 2023-09-30 | -$212.00K 6-K · filed 2024-11-12 | -$447.00K derived: sum of 2 quarters · filed 2024-11-12 | -$525.00K 6-K · filed 2024-11-12 | |
| 2023-06-30 | -$235.00K 6-K · filed 2024-08-13 | -$313.00K 6-K · filed 2024-08-13 | ||
| 2022-12-31 | $1.08M 20-F · filed 2025-04-09 | |||
| 2021-12-31 | $20.00K derived: 20-F/A 12 month − 6-K 9 month · filed 2024-07-17 | $20.00K derived: sum of 2 quarters · filed 2024-07-17 | $20.00K derived: sum of 3 quarters · filed 2024-07-17 | -$109.00K 20-F/A · filed 2024-07-17 |
| 2021-09-30 | $0.00 derived: 6-K 9 month − 6-K/A 6 month · filed 2022-11-03 | $0.00 derived: sum of 2 quarters · filed 2022-11-03 | -$129.00K 6-K · filed 2022-11-03 | |
| 2021-06-30 | $0.00 derived: 6-K/A 6 month − 6-K 3 month · filed 2022-08-04 | -$129.00K 6-K/A · filed 2022-08-04 | ||
| 2021-03-31 | -$129.00K 6-K · filed 2022-05-11 | |||
| 2020-12-31 | $395.00K 20-F/A · filed 2024-02-15 | |||
| 2019-12-31 | -$188.00K 20-F · filed 2022-03-29 | |||
| 2018-12-31 | -$636.00K derived: 20-F 12 month − 6-K 9 month · filed 2020-03-31 | -$1.18M derived: sum of 2 quarters · filed 2020-03-31 | -$1.42M derived: sum of 3 quarters · filed 2020-03-31 | $5.45M 20-F · filed 2020-03-31 |
| 2018-09-30 | -$547.00K 6-K · filed 2019-11-07 | -$780.00K derived: sum of 2 quarters · filed 2019-11-07 | $6.09M 6-K · filed 2019-11-07 | |
| 2018-06-30 | -$233.00K 6-K · filed 2019-08-13 | $6.63M 6-K · filed 2019-08-13 | ||
| 2017-12-31 | -$3.48M 20-F · filed 2020-03-31 | |||
| 2016-12-31 | $0.00 20-F · filed 2019-04-01 | |||
| 2015-12-31 | $0.00 20-F · filed 2018-03-28 |